Authors

• Li Xuan (ORCID: https://orcid.org/0000-0002-6176-7411)
• Ren Lin (ORCID: https://orcid.org/0000-0002-9402-0883)
• Fen Huang
• Xuan Zhou (ORCID: https://orcid.org/0000-0003-2522-1283)
• Ziyu Wen
• Hongsheng Zhou (ORCID: https://orcid.org/0000-0002-4888-7021)
• Xiaofang Li
• Qiang Wang (ORCID: https://orcid.org/0000-0002-7604-8153)
• Zhi Liu (ORCID: https://orcid.org/0000-0003-2091-1592)
• Xiaoli Liu (ORCID: https://orcid.org/0000-0003-1686-3292)
• Zhiping Fan (ORCID: https://orcid.org/0000-0002-7137-0151)
• Xu Ye (ORCID: https://orcid.org/0009-0006-5336-3077)
• Na Xu
• Jing Sun (ORCID: https://orcid.org/0000-0002-5130-4835)
• Hua Jin (ORCID: https://orcid.org/0000-0002-1988-8009)
• Qifa Liu
• Min Dai (ORCID: https://orcid.org/0000-0002-0099-4725)

Institutions

• Second Affiliated Hospital of Guangzhou Medical University (CN)
• Nanfang Hospital (CN)
• Guangdong Provincial Center for Disease Control and Prevention (CN)
• Guangdong Provincial People's Hospital (CN)
• Southern Medical University (CN)
• Guangzhou Medical University (CN)

Publication Details

Journal

Frontiers in Immunology

Published

2025-05-14

DOI

https://doi.org/10.3389/fimmu.2025.1546371

Citations

4

Primary Topic

Chronic Myeloid Leukemia Treatments

Type

article

Field-Weighted Citation Impact

7.08